Image source: Getty Images
Shares in FTSE 250 private hospital provider Spire Healthcare Group (LSE: SPI) spiked up 14% on 19 September.
In response to media speculation, the company told us it doesn’t think its market cap fully reflect its underlying value. The board confirmed it’s “commenced a process to hold discussions with a number of parties in relation to a range of potential options“.
Those options “may include … a potential sale of the company“. But the announcement stressed it’s all “highly preliminary and no decision has been made regarding whether any such option will be pursued at this stage“.
Time to buy?
What should potential investors do now? Some might buy in the hope the company is sold and they can bag a quick profit. In fact, the price rise suggests some already have. That’s always a gamble, and could well result in a loss should there be no sale. I’d never buy…
